chapter 1 Physical Stability of Dispersed Systems / chapter 2 Biopharmaceutical Principles of Injectable Dispersed Systems / chapter 3 Characterization and Analysis of Dispersed Systems / chapter 4 In Vitro=In Vivo Release from Injectable Dispersed Systems / chapter 5 In Vitro=In Vivo Correlation for Modified Release Injectable Drug Delivery Systems / chapter 6 Coarse Suspensions: Design and Manufacturing / chapter 7 Emulsions: Design and Manufacturing / chapter 8 Liposomes: Design and Manufacturing / chapter 9 Microspheres: Design and Manufacturing / chapter 10 Case Study: Development and Scale-Up of NanoCrystal Particles / chapter 11 Case Study: Formulation Development and Scale-Up Production of an Injectable Perfluorocarbon Emulsion / chapter 12 Case Study: A Lipid Emulsion Sterilization / chapter 13 Case Study: Formulation of an Intravenous Fat Emulsion / chapter 14 Case Study: DOXIL, the Development of Pegylated Liposomal Doxorubicin / chapter 15 Case Study: AmBisome�A Developmental Case Study of a Liposomal Formulation of the Antifungal Agent Amphotericin B / chapter 16 Case Study: Optimization of a Liposomal Formulation with Respect to Tissue Damage / chapter 17 Case Study: In Vitro/In Vivo Release from Injectable Microspheres / chapter 19 Injectable Dispersed Systems: Quality and Regulatory Considerations / chapter 20 Regulatory Considerations for Controlled Release Parenteral Drug Products: Liposomes and Microspheres